Abstract:We consider the problem of estimating the effects of a binary treatment on a continuous outcome of interest from observational data in the absence of confounding by unmeasured factors. We provide a new estimator of the population average treatment effect (ATE) based on the difference of novel double-robust (DR) estimators of the treatment-specific outcome means. We compare our new estimator with previously estimators both theoretically and via simulation. DR-difference estimators may have poor finite sample behavior when the estimated propensity scores in the treated and untreated do not overlap. We therefore propose an alternative approach, which can be used even in this unfavorable setting, based on locally efficient double-robust estimation of a semiparametric regression model for the modification on an additive scale of the magnitude of the treatment effect by the baseline covariates $X$. In contrast with existing methods, our approach simultaneously provides estimates of: i) the average treatment effect in the total study population, ii) the average treatment effect in the random subset of the population with overlapping estimated propensity scores, and iii) the treatment effect at each level of the baseline covariates $X$. When the covariate vector $X$ is high dimensional, one cannot be certain, owing to lack of power, that given models for the propensity score and for the regression of the outcome on treatment and $X$ used in constructing our DR estimators are nearly correct, even if they pass standard goodness of fit tests. Therefore to select among candidate models, we propose a novel approach to model selection that leverages the DR-nature of our treatment effect estimator and that outperforms cross-validation in a small simulation study.

Robust Causal Inference of Drug-drug Interactions

A Bayesian Meta-Analysis on Published Sample Mean and Variance Pharmacokinetic Data with Application to Drug–Drug Interaction Prediction

Double-robust and efficient methods for estimating the causal effects of a binary treatment

Bayesian propensity scores for high-dimensional causal inference: A comparison of drug-eluting to bare-metal coronary stents

High-dimensional model-assisted inference for treatment effects with multi-valued treatments

An Inverse Probability Weighted Regression Method that Accounts for Right-censoring for Causal Inference with Multiple Treatments and a Binary Outcome

Multiple-model-based robust estimation of causal treatment effect on a binary outcome with integrated information from secondary outcomes

Augmented Weighted Estimators Dealing with Practical Positivity Violation to Causal inferences in a Random Coefficient Model

Robust inference for causal mediation analysis of recurrent event data

Estimation of causal effects of multiple treatments in healthcare database studies with rare outcomes

Debiased Inverse Propensity Score Weighting for Estimation of Average Treatment Effects with High-Dimensional Confounders

Proposing a framework to quantify the potential impact of pharmacokinetic drug–drug interactions caused by a new drug candidate by using real world data about the target patient population

Systematic Prediction of Pharmacodynamic Drug-Drug Interactions Through Protein-Protein-Interaction Network.

Identification of Drug-Drug Interactions Using Chemical Interactions

Predicting drug–drug interactions through drug structural similarities and interaction networks incorporating pharmacokinetics and pharmacodynamics knowledge

Identification of adverse drug-drug interactions through causal association rule discovery from spontaneous adverse event reports

Generalization Bounds for Estimating Causal Effects of Continuous Treatments

Propensity score‐adjusted three‐component mixture model for drug‐drug interaction data mining in FDA Adverse Event Reporting System

Robust Estimation of Causal Effects via High-Dimensional Covariate Balancing Propensity Score

A New Covariate Selection Strategy for High Dimensional Data in Causal Effect Estimation with Multivariate Treatments

A Bayesian method to detect drug‐drug interaction using external information for spontaneous reporting system